Ashland (ASH) Reports Q3 2025 Earnings with Revenue Decline and Goodwill Impairment
Ashland (ASH) reported Q3 2025 earnings with a 15% year-over-year revenue decline to $463 million, driven by portfolio optimization and lower organic sales. The company also recorded a $706 million goodwill impairment charge, primarily in Life Sciences and Specialty Additives, and saw adjusted EBITDA fall 19% to $113 million.
Topics: adjusted EBITDA earnings report goodwill impairment portfolio optimization revenue decline